I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Ribaldone, D G
208
results:
Online X
english X
Search for persons
X
Format
Online (208)
Mediatypes
Articles (Online) (99)
Bookchapter (Online) (2)
OpenAccess-fulltext (107)
Sorted by: Relevance
Sorted by: Year
?
1
P621 Safety and effectiveness of vedolizumab and ustekinuma..:
Holvoet, T
;
Verstockt, B
;
Lenfant, M
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1195-i1196 , 2024
Link:
https://doi.org/10.1093/..
?
2
P1016 Real-world data on sequential therapy in moderate-to-..:
Farkas, B
;
Borsos, M
;
Resál, T
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1837-i1838 , 2024
Link:
https://doi.org/10.1093/..
?
3
P508 Pre-operative exposure to tofacitinib is as safe as bi..:
Dragoni, G
;
Innocenti, T
;
Amiot, A
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1005-i1006 , 2024
Link:
https://doi.org/10.1093/..
?
4
A 1-year follow-up study on checkpoint inhibitor-induced co..:
Lenti, M.V.
;
Ribaldone, D.G.
;
Borrelli de Andreis, F.
...
ESMO Open. 9 (2024) 7 - p. 103632 , 2024
Link:
https://doi.org/10.1016/..
?
5
P576 Fecal calprotectin could predict clinical and endoscop..:
Bertani, L
;
Tricò, D
;
Barberio, B
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1125-i1125 , 2024
Link:
https://doi.org/10.1093/..
?
6
P729 Prospective observational study evaluating the effects..:
Piumatti, A
;
Beccuti, G
;
Armandi, A
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1369-i1369 , 2024
Link:
https://doi.org/10.1093/..
?
7
OC.04.7: A ONE-YEAR FOLLOW-UP STUDY ON CHECKPOINT INHIBITOR..:
Lenti, M.V.
;
Broglio, G.
;
Ribaldone, D.G.
...
Digestive and Liver Disease. 56 (2024) - p. S144-S145 , 2024
Link:
https://doi.org/10.1016/..
?
8
OC.07.2: ASSESSMENT OF VEDOLIZUMAB AND USTEKINUMAB IN ELDER..:
Viola, A.
;
Ventimiglia, M.
;
Sparacino, A.
...
Digestive and Liver Disease. 56 (2024) - p. S161-S163 , 2024
Link:
https://doi.org/10.1016/..
?
9
P908 Real-life effectiveness and safety of tofacitinib and ..:
Noviello, D
;
Savarino, E
;
Fries, W
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1660-i1661 , 2024
Link:
https://doi.org/10.1093/..
?
10
DOP79 Promising efficacy of biologicals and small molecules..:
Verstockt ., B
;
Taelman, T
;
Vavricka, S R
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i219-i221 , 2024
Link:
https://doi.org/10.1093/..
?
11
BOC.03.3: TREATMENT OF ANTIBIOTIC REFRACTORY CHRONIC POUCHI..:
Testa, G.
;
Ribaldone, D.G.
;
Verstockt, B.
...
Digestive and Liver Disease. 56 (2024) - p. S115-S116 , 2024
Link:
https://doi.org/10.1016/..
?
12
P539 Assessment of VEdolizumab aNd Ustekinumab in Elderly p..:
Viola, A
;
Ventimiglia, M
;
Sparacino, A
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1059-i1061 , 2024
Link:
https://doi.org/10.1093/..
?
13
Effect of Periodontitis and Periodontal Therapy on Oral and..:
Baima, G.
;
Ferrocino, I.
;
Del Lupo, V.
...
Journal of Dental Research. 103 (2024) 4 - p. 359-368 , 2024
Link:
https://doi.org/10.1177/..
?
14
P612 Switching from intravenous to subcutaneous VEDOlizumab..:
Ribaldone, D G
;
Parisio, L
;
Variola, A
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1185-i1185 , 2024
Link:
https://doi.org/10.1093/..
?
15
P735 JAK inhibitors and S1P receptor modulators for the tre..:
Testa, G
;
Ribaldone, D G
;
Verstockt, B
...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1377-i1379 , 2024
Link:
https://doi.org/10.1093/..
1-15